| White matter changes in Alzheimer's disease: a focus on myelin and oligodendrocytes |
62 |
| A walk through tau therapeutic strategies |
56 |
| Rapid and ultra-sensitive quantitation of disease-associated alpha-synuclein seeds in brain and cerebrospinal fluid by alpha Syn RT-QuIC |
48 |
| Phosphorylation of different tau sites during progression of Alzheimer's disease |
34 |
| Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration |
30 |
| Comprehensive gene expression meta-analysis identifies signature genes that distinguish microglia from peripheral monocytes/macrophages in health and glioma |
27 |
| Exosomes taken up by neurons hijack the endosomal pathway to spread to interconnected neurons |
27 |
| TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer's disease |
26 |
| Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration |
26 |
| Amyloid-beta and phosphorylated tau in post-mortem Alzheimer's disease retinas |
24 |
| Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer's disease |
23 |
| Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer's disease |
23 |
| ALS-linked FUS mutations confer loss and gain of function in the nucleus by promoting excessive formation of dysfunctional paraspeckles |
23 |
| RNA binding proteins co-localize with small tau inclusions in tauopathy |
22 |
| Intersection of pathological tau and microglia at the synapse |
21 |
| Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers |
20 |
| Complement 3(+)-astrocytes are highly abundant in prion diseases, but their abolishment led to an accelerated disease course and early dysregulation of microglia |
19 |
| Alzheimer's disease tau is a prominent pathology in LRRK2 Parkinson's disease |
19 |
| Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination |
19 |
| The genetic landscape of ganglioglioma |
19 |
| Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors |
18 |
| Early neuronal accumulation of DNA double strand breaks in Alzheimer's disease |
18 |
| Iatrogenic Creutzfeldt-Jakob disease with Amyloid-beta pathology: an international study |
18 |
| The elusive tau molecular structures: can we translate the recent breakthroughs into new targets for intervention? |
17 |
| Neutrophil extracellular trap induced by HMGB1 exacerbates damages in the ischemic brain |
17 |
| Low-level blast exposure disrupts gliovascular and neurovascular connections and induces a chronic vascular pathology in rat brain |
17 |
| Unique microglia recovery population revealed by single-cell RNAseq following neurodegeneration |
17 |
| Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours |
16 |
| Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre |
16 |
| Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945 |
16 |
| Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer's disease |
16 |
| Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia |
16 |
| Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic latera sclerosis |
15 |
| Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue |
15 |
| Transcriptomic and epigenetic profiling of diffuse midline gliomas, H3 K27M-mutant' discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location |
15 |
| Decoding the synaptic dysfunction of bioactive human AD brain soluble A to inspire novel therapeutic avenues for Alzheimer's disease |
15 |
| Immune landscapes associated with different glioblastoma molecular subtypes |
15 |
| C9orf72 intermediate expansions of 24-30 repeats are associated with ALS |
15 |
| Forced turnover of aged microglia induces an intermediate phenotype but does not rebalance CNS environmental cues driving priming to immune challenge |
14 |
| The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer's disease in individuals with Down syndrome |
14 |
| Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA) |
14 |
| alpha-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb |
14 |
| Compromised astrocyte function and survival negatively impact neurons in infantile neuronal ceroid lipofuscinosis |
14 |
| Different tau species lead to heterogeneous tau pathology propagation and misfolding |
14 |
| Membrane binding, internalization, and sorting of alpha-synuclein in the cell |
14 |
| Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies |
13 |
| Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model |
13 |
| alpha-Synuclein fibril-induced paradoxical structural and functional defects in hippocampal neurons |
13 |
| Understanding the pathogenesis of multiple system atrophy: state of the art and future perspectives |
13 |
| Poly-GR dipeptide repeat polymers correlate with neurodegeneration and Clinicopathological subtypes in C9ORF72-related brain disease |
13 |
